LaserCare
ActiveSummary
LaserCare has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€842) and a net result of -€3,394. Equity is shrinking by about 16% per year across the filed financial years. Its solvency ranks better than 5% of 20,604 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
28-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 28 days late
2025
26-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 26 days late
2024
29-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 29 days late
2023
31-12
Financial
Weakest financial yearnet -€11,494
Net result drops to -€11,494, the lowest in the series; recovery starts the following year.
03-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 3 days late
2022
31-12
Financial
Back to profitnet €12,205
Net result €12,205 after 2 loss-making years.
31-12
Financial
Liquidity times 11current ratio 10.87
Current ratio from 0.99 to 10.87; short-term debt falls from €14,044 to €888.
27-06
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
26-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 26 days late
2020
22-09
NBB filing
Annual accounts filed
financial year 2019 · micro format · 53 days late
2019
31-12
Financial
Back to profitnet €14,932
Net result €14,932 after one loss-making year.
27-08
NBB filing
Annual accounts filed
financial year 2018 · micro format · 27 days late
2018
30-08
NBB filing
Annual accounts filed
financial year 2017 · micro format · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 4 deeds read
About the unread acts
We know of 4 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.